(Q74713919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

12 November 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

8

Gratwohl A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Meyer-Monard S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Gregor M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Favre G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Heim D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ebnoether M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Tichelli A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

267-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209347%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703671

12 November 2019

exact match

0 references

cites work

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021

Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703671

7 January 2021